GSK Investigational Site
Canoga Park, California 91306
1 studies enrolling now · 6 studies all time
What they study most
Asthma, Chickenpox, Dermatitis, Atopic, Infections, Meningococcal, Influenza, Human, Respiratory Syncytial Virus Infections
Studies at this site
- A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine When Given to Healthy Children 12 to 15 Months of Age — Recruiting now
- A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis — Stopped early
- A Study to Evaluate the Immune Response and Safety of an Influenza Vaccine in Adults 18 Years of Age and Above — Running, not enrolling
- A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above — Completed
- Effectiveness of GlaxoSmithKline Biologicals S.A's Meningococcal Group B and Combined ABCWY Vaccines in Healthy Adolescents and Young Adults — Completed
- 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed